Diabetes-induced Alterations in HDL Subfractions Distribution

Area of Science:

• Cardiology
• Endocrinology
• Metabolic Diseases

Background:

• Diabetes mellitus (DM) is a growing public health concern with significant morbidity and mortality.
• In DM, high-density lipoprotein (HDL) can lose its protective functions, becoming proatherogenic and elevating cardiovascular risk.
• Understanding HDL subfraction changes in DM is crucial for managing cardiovascular complications.

Purpose of the Study:

• To investigate how type 2 DM and its duration affect HDL subfraction distribution.
• To evaluate the impact of statin therapy on HDL subfraction composition in diabetic patients.

Main Methods:

• The study included 50 patients with newly diagnosed type 2 DM, 50 with DM >10 years, and 50 healthy controls.
• HDL subfractions were analyzed using the Lipoprint system.

Main Results:

• Advanced type 2 DM was associated with impaired heart function and structure.
• Patients with advanced DM had significantly lower levels of HDL-6 and intermediate HDL fractions compared to newly diagnosed DM patients and controls.
• Statin treatment did not appear to yield beneficial effects on HDL subfractions.

Conclusions:

• Diabetes mellitus compromises HDL's antiatherogenic properties through oxidative modification and glycation.
• These HDL alterations in DM contribute to increased cardiovascular risk.
• Further research is needed to clarify the complex interactions between DM, HDL, and cardiovascular outcomes.